期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 173, 期 6, 页码 938-940出版社
WILEY
DOI: 10.1111/bjh.13644
关键词
myelofibrosis; CALR; ruxolitinib; JAK inhibitor; myeloproliferative neoplasm